Abstract
Nothing is more challenging to the physician than the management of a serious infection in an immunocompromised host. Under such circumstances, the clinician must bring to bear all of his knowledge of microbiology and antimicrobial therapy, but in addition, he must have a firm understanding of the host defense abnormality underlying that individual patient’s disease. As indicated by Stollerman in a recent review,1 we can no longer have a primarily parasite-oriented approach to infectious diseases but must include host factors in the data on which we make potentially life-saving decisions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Stollerman GH: Immunologic deficiencies in the training of physicians. J. Chronic Dis 26: 679–688, 1973.
Hermans PE, Diaz-Buxo JA, Stobo JD: Idiopathic late-onset 22. immunoglobulin deficiency, Am J Med 61: 221–237, 1976.
Hill HR: Evaluating the patient with recurrent infections. South Med J 70: 230–235, 1977. 23.
Hill HR: Laboratory aspects of immune deficiency in children. Pediatr. Clin North Am 27: 805–830, 1980.
Hill HR: Immunodeficiency diseases. In Stefanini M, Benson ES(eds): Progress in Clinical Pathology. Grune und StrattonNew York, 1981, pp. 205–238.
Johnston RB Jr, Janeway CA: The child with frequent infections: Diagnostic considerations, Pediatrics 43: 596–600, 1969.
Johnston RB Jr, Lawton AR III, Cooper MD: Disorders of host defense against infection: Pathophysiologic and diagnostic considerations. Med Clin North Am 57: 421–440, 1973.
Dingle JH, Badger GF, Jordan WS Jr: Illness in the Home. Cleveland, Press of Case Western Reserve University, 1964.
Kretschmer R, Say B, Brown D: Congenital aplasia of the thymus gland (DiGeorge’s syndrome). N Engl J Med 279: 1295–1301, 1968.
Groshong T, Horowitz S, Lovchik J, et al: Chronic cytomegalovirus infection, immunodeficiency, and monoclonal gammopathy-antigen-driven malignancy. J Pediatr 88: 217–223, 1976.
Lawlor GJ Jr., Ammann AJ, Wright WC Jr., et al: The syndrome of cellular immunodeficiency with immunoglobulins. J Pediatr 84: 183–192, 1974.
Ammann AJ: T Cell and T—B cell immunodeficiency disorders. In Miller ME (ed): The Child with Recurrent Infection. WB Saunders, Philadelphia, 1977, pp. 293–311.
Jondal M, Holm G, Wigzell H: Surface markers on human T and B lymphocytes. I. A large population of lymphocytes forming nonimmune rosettes with sheep red blood cells. J Exp Med 136: 207–215, 1972.
Goldman AS, Goldblum RM: Primary deficiencies in humoral immunity. In Miller ME (ed): The Child with Recurrent Infection. WB Saunders, Philadelphia, 1977, pp. 277291.
Hecht F, McCaw BK, Koler RD: Ataxia-telangiectasiaclonal growth of translocation lymphocytes. N Engl J Med 289: 286–291, 1973.
Ballow M, Shira JE, Harden L, et al: Complete absence of the third component of complement in man. J Clin Invest 56: 703–710, 1975.
Alper CA, Colten HR, Gear JSS, et al: Homozygous human C3 deficiency. J Clin Invest 57: 222–229, 1976.
Miller ME, Seals J, Kaye R, et al: A familial, plasma-associated defect of phagocytosis: A new cause of recurrent bacterial infections. Lancet 2: 60–63, 1968.
Rosenfeld SI, Baum J, Steigbigel RT, et al: Hereditary deficiency of the fifth component of complement in man. J Clin Invest 57: 1635–1643, 1976.
Leddy JP, Frank MM, Gaitner I, et al: Hereditary deficiency of the sixth component of complement in man. J Clin Invest 53: 544–553, 1974.
Boyer JT, Gall EP, Norman ME, et al: Hereditary deficiency of the seventh component of complement. J Clin Invest 56: 905–913, 1975.
Petersen BH, Graham JA, Brooks GF: Human deficiency of the eighth component of complement. J Clin Invest 57: 283–290, 1976.
Petersen BH, Lee TJ, Snyderman RJ: Neisseria meningitidis and Neisseria gonorrheae bacteremia associated with C6, C7, or C8 deficiency. Ann Intern Med 90: 917–920, 1979.
Hill HR, Quie PG: Raised serum-IgE levels and defective neutrophil chemotaxis in three children with eczema and recurrent bacterial infections. Lancet 1: 183–187, 1974.
Hill HR, Quie PG: Defective neutrophil chemotaxis associated with hyperimmunoglobulinemia E. In Bellanti JA, Dayton DH (eds): The Phagocytic Cell in Host Resistance. Raven, New York, 1975, pp. 249–266.
Miller ME, Oski FA, Harris MB: Lazy-leucocyte syndrome. Lancet 1: 665–669, 1971.
Johnston RB Jr, Baehner RL: Chronic granulomatous disease: Correlation between pathogenesis and clinical findings. Pediatrics 48: 730–739, 1971.
Oh MK, Rodey GE, Good RA, et al: Defective candicidal capacity of polymorphonuclear leukocytes in chronic granulomatous disease of childhood. J Pediatr 75: 300–303, 1969.
Curnutte JT, Whitten DM, Babior BM: Defective superoxide production by granulocytes from patients with chronic granulomatous disease. N Engl J Med 290: 593–596, 1974.
Holmes B, Park BH, Malawista SE: Chronic granulomatous disease in females: A deficiency of leukocyte glutathione peroxidase. N Engl J Med 283: 217–221, 1970.
Quie PG, Hill HR: Granulocytopathies. DM 1: 1–32, 1973.
Quie PG: Bactericidal function of human polymorphonuclear leukocytes. Pediatrics 50: 264–270, 1972.
Van Scoy RE, Hill HR, Ritts RE Jr., et al: Familial neutrophil chemotaxis defect, recurrent bacterial infections, mucocutaneous candidiasis and hyperimmunoglobulinemia E. Ann Intern Med 82: 766–771, 1975.
Baehner RL, Nathan DG: Quantitative nitroblue tetrazolium test in chronic granulomatous disease, N Engl J Med 278: 971–980, 1968.
Park BH: The use and limitations of the nitroblue tetrazolium test as a diagnostic aid. J Pediatr 78: 376–378, 1971.
Cheson BD, Christensen RL, Sperling R, et al: The origin of the chemiluminescence of phagocytizing granulocytes. J Clin Invest 58: 789–796, 1976.
Shigeoka AO, Santos JI, Hill HR: Functional analysis of neutrophil granulocytes from healthy, infected and stressed neonates. J Pediatr 95: 454–469, 1979.
Allen RC, Stjemholm RL, Steele RH: Evidence for the generation of an electronic excitation state(s) in human polymorphonuclear leukocytes and its participation in bactericidal activity. Biochem Biophys Res Commun 47: 679–684, 1972.
Allen RC, Yevich SJ, Orth RW, et al: The superoxide anion and singlet molecular oxygen: Their role in the microbicidal activity of the polymorphonuclear leukocyte. Biochem Biophys Res Commun 60: 909–917, 1974.
Stevens P, Winston DJ, Van Dyke K: In vitro evaluation of opsonic and cellular granulocyte function by luminol-dependent chemiluminescence: Utility in patients with severe neutropenia and cellular deficiency states. Infect Immun 22: 4151, 1978.
Rosen H, Klebanoff SJ: Chemiluminescence and superoxide production by myeloperoxidase-deficient leukocytes. J Clin Invest 58: 50–60, 1976.
Shigeoka AO, Hill HR: Recurrent pseudomonas infection associated with neutrophil dysfunction. Scand J Infect Dis 10: 307–311, 1978.
Quie PG, White JG, Holmes B: In vitro bactericidal capacity of human polymorphonuclear leukocytes: Diminished activity in chronic granulomatous disease of childhood. J Clin Invest 46: 668–679, 1967.
Ward PA, Cochrane CG, Müller-Eberhard RI: The role of serum complement in chemotaxis of leukocytes in vitro. J Exp Med 122: 327–346, 1965.
Hill HR, Hogan NA, Mitchell TG, et al: Evaluation of a cytocentrifuge method for measuring neutrophil granulocyte chemotaxis. J Lab Clin Med 86: 703–710, 1975.
Cutler JE: A simple in vitro method for studies on chemotaxis. Proc Soc Exp Biol Med 147: 471–474, 1974.
Nelson RD, Quie PG, Simmons RL: Chemotaxis under agarose: A new and simple method for measuring chemotaxis and spontaneous migration of human polymorphonuclear leukocytes and monocytes. J Immunol 115: 1650–1656, 1975.
Miller ME: Leukocyte movement—in vitro and in vivo correlates. J Pediatr 83: 1104–1106, 1973.
Hill HR, Quie PG, Pabst HF, et al: Defect in neutrophil granulocxte chemotaxis in Job’s syndrome or recurrent “cold” staphylococcal abscesses. Lancet 2: 617–619, 1974.
Ayoub EM, Dudding BA, Cooper MD: Dichotomy of antibody response to group A streptococcal antigen in WiskottAldrich syndrome. J Lab Clin Med 72: 971–979, 1968.
Blaese, RM, Strober W, Waldmann TA: Immunodeficiency in Wiskott–Aldrich syndrome. Birth Defects 11: 250–254, 1975.
Ezer G, Soothill JF: Intracellular bactericidal effects of rifampin in both normal and chronic granulomatous disease polymorphs. Arch Dis Child 49: 463–466, 1974.
Philippart AI, Colodny AH, Baehner RL: Continuous antibiotic therapy in chronic granulomatous disease: Preliminary communication. Pediatrics 50: 923–925, 1972.
Hahn HH, Beaty HN: Transtracheal aspiration in the evaluation of patients with pneumonia. Ann Intern Med 72: 183–187, 1970.
Hughes JR, Sinha DP, Cooper MR, et al: Lung top in childhood. Pediatrics 41: 477–484, 1969.
Finaldn M: Diagnostic lung puncture. Pediatrics 44: 471–485, 1969.
Wolff Li, Bartlett MS, Baehner RL: The causes of interstitial pneumonitis in immunocompromised children: An aggressive systematic approach to diagnosis. Pediatrics 60: 41–49, 1977.
Rytel MW: Counterimmunoelectrophoresis in diagnosis of infectious disease. Hosp Pract 10: 75–82, 1975.
Coonrod JD, Rytel MW: Determination of aetiology of bacterial meningitis by counterimmunoelectrophoresis. Lancet 1: 1154–1157, 1972.
Rytel MW: Rapid diagnostic methods in infectious diseases. Adv Intern Med 20: 37–60, 1975.
Hill HR: Rapid detection of specific identification of infections due to group B streptococci by counterimmunoelectrophoresis. In Borodina VM, Meisel MN (eds): Microbiol 1975 (Vol. 44) American Society for Microbiology, Washington, DC, 1975, pp. 84–88.
Edwards EH, Muehl PM, Peckinpaugh RO: Diagnosis of bacterial meningitis by counterimmunoelectrophoresis. J Lab Clin Med 80: 449–454, 1972.
Smith EWP, Ingram DL: Counterimmunoelectrophoresis in Hemophilus influenzae type B epiglottis and pericarditis. J Pediatr 86: 571–573, 1975.
Ingram DL, Anderson P, Smith DH: Countercurrent immunoelectrophoresis in the diagnosis of systemic diseases caused by Hemophilus influenzae, type B. J Pediatr 81: 1156–1159, 1972.
Coonrod JD, Leach RP: Antigenemia in fulminant pneumococcemia. Ann Intern Med 84: 561–563, 1976.
Fossieck B Jr, Craig R, Paterson PY: Counterimmunoelectrophoresis for rapid diagnosis of meningitis due to Diplococcus pneumoniae. J Infect Dis 127: 106–109, 1973.
Coonrod JD, Rytel MW: Detection of type-specific pneumococcal antigens by counterimmunoelectrophoresis. I. Methodology and immunologic properties. J Lab Clin Med 81: 770–777, 1973.
Ferstenfeld JE, Rytel MW: Fulminating meningococcemia with high serum level of meningococcal capsular antigen. JAMA 22: 1301–1302, 1974.
Greenwood BM, Whittle HC, Dominic-Rajkovic O: Counter-current immunoelectrophoresis in the diagnosis of meningococcal infections. Lancet 2: 519–521, 1971.
Fallon RJ: Escherichia coli K1. Lancet 1: 201, 1976.
Bartram CE, Crowder JG, Beeler B, et al: Diagnosis of bacterial diseases by detection of serum antigens by counterimmunoelectrophoresis, sensitivity, and specificity of detecting Pseudomonas and pneumococcal antigens. J Lab Clin Med 83: 591–598, 1974.
Hill HR, Riter ME, Menge SK, et al: Rapid identification of group B streptococci by counterimmunoelectrophoresis. J Clin Microbiol 1: 188–191, 1975.
Portas MR, Hogan NA, Hill HR: Rapid specific identification of group D streptococci by counterimmunoelectrophoresis. J Lab Clin Med 88: 339–344, 1976.
Wenzel RP, Teates CD, Galapon Q, et al: Acute viral hepatitis in adults: Comparison of the radioimmunoassay and counterimmunoelectrophoresis methods of detecting HBSAg. JAMA 232: 366–368, 1975.
Cho HJ, Langford EV: Rapid detection of bovine mycoplasma antigens by counterimmunoelectrophoresis. Appl Microbiol 28: 897–899, 1974.
Pifer LL, Hughes WT, Stagno S: Pneumocystis carinii infection: Evidence for high prevalence in normal and immunosuppressed children. Pediatrics 61: 35–41, 1978.
Myers JD, Pifer LL, Sale GE, et al: Value of Pneumocystis carinii antibody and antigen detection for diagnosis of Pneumocystis carinii pneumonia after marrow transplantation. Am Rev Respir Dis 120: 181–182, 1979.
Shackelford PG, Campbell J, Feigin RD: Countercurrent immunoelectrophoresis in the evaluation of childhood infections. J Pediatr 85: 478–481, 1974.
Dorff GJ, Coonrod JD, Rytel MW: Detection by immunoelectrophoresis of antigen in sera of patients with pneumococcal bacteremia. Lancet 1: 578–579, 1971.
Feigin RD, Wong M, Shackelford PG, et al: Countercurrent immunoelectrophoresis of urine as well as of CSF and blood for diagnosis of bacterial meningitis. J Pediatr 89: 773–775, 1976.
Colding H, Lind I: Counterimmunoelectrophoresis in the diagnosis of bacterial meningitis. J Clin Microbiol 5: 405–409, 1977.
Hill HR: Detection of bacterial antigens in meningitis. American Society of Clinical Pathology, Check Sample MB 82–3, 1982.
El-Refaie M, Dulake C: Counter-current immunoelectrophoresis in the diagnosis of pneumococcal chest infections. J Clin Pathol 28: 801–806, 1975.
Michaels RH, Poziviak CS: Countercurrent immunoelectrophoresis for the diagnosis of pneumococcal pneumonia in children. J Pediatr 88: 72–74, 1976.
Sottile MI, Rytel MW: Application of counterimmunoelectrophoresis in the identification of Streptococcus pneumoniae in clinical isolates. J Clin Microbiol 2: 173177, 1975.
Bradshaw MW, Parke JL, Schneerson R, et al: Bacterial antigens cross-reactive with the capsular polysaccharide of Haemophilus influenzae type B. Lancet 1: 1095–1096, 1971.
Miller J, Sande MA, Gwaltney JM, et al: Diagnosis of pneumococcal pneumonia by antigen detection in sputum. J Clin Microbiol 7: 459–462, 1978.
Remington JS, Gaines JD, Gilmer MA: Demonstration of Candida precipitins in human sera by counterimmunoelectrophoresis. Lancet 1: 413–415, 1972.
Dee TH, Rytel MW: Clinical applications of counterimmunoelectrophoresis in detection of Candida serum precipitins. J Lab Clin Med 85: 161–166, 1975.
Guinan ME, Portas MR, Hill HR: The Candida precipitin test in an immunosuppressed population. Cancer 43: 299–302, 1979.
Crowder JG, White A: Teichoic acid antibodies in staphylococcal and nonstaphylococcal endocarditis. Ann Intern Med 77: 87–90, 1972.
Tuazon CV, Sheagren J: Teichoic acid antibodies in the diagnosis of serious infections with Staphylococcus aureus. Ann Intern Med 84: 543–546, 1976.
Nagel JG, Tuazon CV, Cardella TA, et al: Teichoic acid serologic diagnosis of staphylococcal endocarditis. Ann Intern Med 82: 13–17, 1975.
Fisher BD, Armstrong D: Cryptococcal interstitial pneumonia. N Engl J Med 297: 1440–1441, 1977.
Newman RB, Stevens RW, Goafar HA: Lat-x agglutination test for the diagnosis of Hemophilus influenzae meningitis. J Lab Clin Med 76: 107–113, 1970.
Zimmerman SE, Smith JW: Identification and grouping of Neisseria meningitidis directly on agar plates by coagglutination with specific antibody-coated protein A-containing staphylococci. J Clin Microbiol 7: 470–473, 1978.
Kaldor J, Asznowicz R, Burst DGP: Latex agglutination in diagnosis of bacterial infections, with special reference to patients with meningitis and septicemia. Am J Clin Pathol 68: 284–289, 1977.
Edwards MS, Kasper DL, Baker CJ: Rapid diagnosis of type III group B streptococcal meningitis by latex particle agglutination. J Pediatr 95: 202–205, 1979.
Nachum R, Lipsey A, Siegel SE: Rapid detection of gram-negative bacterial meningitis by the limulus lysate test. N Engl J Med 289: 931–934, 1973.
Berman NS, Siegel SE, Nachum P, et al: Cerebrospinal fluid endotoxin concentrations in gram-negative bacterial meningitis. J Pediatr 88: 553–556, 1976.
McCracken GH Jr: Rapid identification of specific etiology in meningitis. J Pediatr 88: 706–708, 1976.
Controni G, Rodrigues WJ, Hicks JM, et al: Cerebrospinal fluid lactic acid levels in meningitis. J Pediatr 91: 379–384, 1977.
Cates KL, Gerrard JM, Giebink GS: A penicillin-resistant pneumococcus. J Pediatr 93: 624–626, 1978.
Hughes WT, Feldman S, Chaudhary SC: Comparison of pentamidine isethionate and trimethoprim—sulfamethoxazole in the treatment of Pneumocystis carinii pneumonia. J Pediatr 92: 285–291, 1978.
Lau WK, Young LS: Trimethoprim—sulfamethoxazole treatment of Pneumocystis carinii pneumonia in adults. N Engl J Med 295: 716–718, 1976.
Miller ME: Uses and abuses of plasma therapy in the patient with recurrent infections. JAllergy Clin Immunol 51: 45–56, 1973.
Stiehm ER: Plasma therapy: An alternative to gamma globulin injections in immunodeficiency. Birth Defects 11: 343–346, 1975.
Stiehm ER, Vaerman JP, Fudenberg HH: Plasma infusions in immunologic deficiency states: Metabolic and therapeutic studies. Blood 28: 918–937, 1966.
Good RA, Page AR: Fatal complications of viras hepatitis in two patients with agammaglobulinemia. Am JMed 29: 804–810, 1960.
Gelfand SG: Agammaglobulinemia associated with Australia-antigen-positive chronic active hepatitis Postgrad Med55Ita263–265, 1974.
Ammann AJ, Good RA, Bier D, et al: Long-term plasma infusions in a patient with ataxia—telangiectasia and deficient IgA and IgE. Pediatrics 44: 672–676, 1969.
Henney CS, Ellis EF: Antibody production to aggregated human aG-globulin in acquired hypogammaglobulinemia. N Engl J Med 278: 1144–1146, 1968.
Cunningham-Rundles C, Siegel FP, Smithwick EM, et al: Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease. Ann Intern Med 101: 435–439, 1984.
Condie RM O’Reilly RJ: Prevention of cytomegalovirus infection by prophylaxis with an intravenous, hyperimmune, native unmodified cytomegalovirus globulin. Am J Med 76:5134–5141, 1984.
Mease PJ, Ochs HD, Wedgewood RJ: Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia. N Engl J Med 304: 1278 1281, 1981.
Fudenberg HH, Spitter LE, Levin AS: Treatment of immune deficiency. Am J Pathol 69: 529–535, 1972.
Editorial: Chronic sinusitis. Lancet 1: 442–443, 1974.
Howie VM, Ploussard JH: Simultaneous nasopharyngeal and middle ear exudate cultures in otitis media. Pediatr Dig Feb:31–35, 1971.
Ament ME: Immunodeficiency syndromes and gastrointestinal disease. Pediatr Clin North Am 22: 807–825, 1975.
Binder Hi, Reynolds RD: Control of diarrhea in secondary hypogammaglobulinemia by fresh plasma infusions. N Engl J Med 277 :802–803 1967
Hill HR: Clinical disorders of leukocyte function. In Snyder-man R (ed): Regu! Leukocyte Function: Contemporary Topics in Immunobiology 14 :345–393, 1984
Miles AA, Miles EM, Burke J: The value and duration of defense reactions of the skin to primary lodgement of bacteria. Br J Exp Pathol 38: 79–96, 1957.
Miles AA: The acute reaction of injury as an antimicrobial defense. In Thomas L, Uhr JW, Grant L (eds): International Symposium on Injury, Inflammation and Immunity Williams und Wilkins, Baltimore 1964, pp. 162–182.
Clark RA, Root RK, Kimball HR, et al: Defective neutrophil chemotaxis and cellular immunity in a child with recurrent infections. Ann Intern Med 78: 515–519, 1973.
Horsburgh CR Jr, Kirkpatrick CH: Longterm therapy of chronic mucocutaneous candidiasis with ketoconazole: Experience with twenty-one patients. Am J Med 74: 23–29, 1983.
Horsburgh CR, Carmody PB, Kirkpatrick CH: Treatment of fungal infections in the bones and joints with ketoconazole. J Infect Dis 147:1064–1069, 1983
Perrin JM, Charney E, MacWhinney JB Jr, et al: Sulfasoxazole as chemoprophylaxis for recurrent otitis media. N Engl J Med 291: 664–667, 1974.
Hardin GM, Ronald AR: A controlled study of antimicrobial prophylaxis of recurrent urinary infections in women. N Engl J Med 291: 597–601, 1974.
Hughes WT, Kuhn S, Chaudhary S: Successful chemoprophylaxis for Pneumocystis carinii pneumonitis. N Engl J Med 297 1419–1426 1977
Johnston RB Jr., Wilfert CM, Buckley RH, et al: Enhanced bactericidal activity of phagocytes from patients with chronic granulomatous disease in the presence of sulphisoxazole. Lancet 1: 824–827, 1975.
Ballow M, Dupont B, Good RA: Autoimmune hemolytic anemia in Wiskott—Aldrich syndrome during treatment with transfer factor. J Pediatr 83: 772–780, 1973.
Wybran J, Levin AS, Spitter LE, et al: Rosette-forming cells, immunologic deficiency diseases and transfer factor. N Engl J Med 288: 710–713, 1973.
Pabst HP, Swanson R: Successful treatment of candidiasis with transfer factor. Br Med J 2: 442–443, 1972.
Wara DW, Ammann Ai: Activation of T-cell rosettes in immunodeficient patients by thymosin. Ann NY Acad Sci 249: 308–314, 1975.
Goldstein AL, Cohen GH, Rossio JL, et al: Use of thymosin in the treatment of primary immunodeficiency diseases and cancer. Med Clin North Am 60: 591–606, 1976.
Polmar SH, Stern RC, Schwartz AL, et al: Enzyme replacement therapy for adenosine deaminase deficiency and severe combined immunodeficiency. N Engl J Med 295: 1337–1343, 1976.
Bortin MM, Rimm AA, et al: Severe combined immunodeficiency disease: Characterization of the disease and results of transplantation. JAMA 238: 591–600, 1977.
Hong R: Thymus transplants: A look to the future. Birth Defects 11 :357–360, 1975.
Buckley RH, Whisnant JK, Schiff RI, et al: Correction of severe combined immunodeficiency by fetal liver cells. N Engl J Med 294: 1076–1081, 1976.
Buckley RH: Immunoreconstitution. In Miller ME (ed): The Child with Recurrent Infection. WB Saunders, Philadelphia, 1977, pp. 313–328.
Thomas FD, Stork R, Clift RA, et al: Bone-marrow transplantation. N Engl J Med 292: 832–843, 1975.
Levine AS, Siegel SE, Schreiber AD, et al: Protected environments and prophylactic antibodies. N Engl J Med 288: 477–483, 1973.
Cleveland WW: Immunologic reconstitution in the Di-George Syndrome by fetal thymic transplant. Birth Defects 11: 352–356, 1975.
Ammann AJ, Wara DW, Doyle NE, et al: Thymus transplantation in patients with thymic hypoplasia and abnormal immunoglobulin synthesis. Transplantation 20: 457–466, 1975.
Kirkpatrick CH, Wells SA, Burdick JF, et al: Effects of fetal thymus transplantation on defective cellular immunity. Transplantation 20: 367–369, 1975.
Hill HR, Estensen RD, Quie PG, et al: Modulation of human neutrophil chemotactic responses by cyclic 3’S’-guanosine monophosphate and cyclic 3’5’-adenosine monophosphate. Metabolism 24: 447–456, 1975.
Zurier RB, Weissmann G, Hoffstein S, et al: Mechanism of lysosomal enzyme release from human leukocytes. II. Effects of cAMP and cGMP, autonomic agonists, and agents which affect microtubule function. J Clin Invest 53: 297–309, 1974.
Oliver JM, Zurier RB: Correction of characteristic abnormalities of microtubule function and granule morphology in Chediak—Higashi syndrome with cholinergic agonists. J Clin Invest 57: 1239–1247, 1976.
Boyer LA, Watanabe AM, Rister M, et al: Correction of leukocyte function in Chediak—Higashi syndrome by ascorbate. N Engl J Med 295: 1041–1045, 1976.
Goetzl EJ, Wasserman SI, Gigli I, et al: Enhancement of random migration and chemotactic response of human leukocytes by ascorbic acid. J Clin Invest 53: 813–818, 1974.
Verhaegen H, DeCree J, Cock WD, et al: Levamisole and the immune response. N Engl J Med 289: 1148–1149, 1973.
Hoekeke J, Franchi G: Influence of tetramisole and its optical isomers on the mononuclear phagocytic system. Effect on carbon clearance in mice. J Reticuloendothel Soc 14: 317–323, 1973.
Pike MC, Synderman R: Augmentation of human monocyte chemotactic response by levamisole. Nature (Lond) 201: 136–137, 1976.
Hogan NA, Hill HR: Levamisole enhances PMN chemotaxis and elevates cellular cyclic GMP. J Infect Dis 138: 437–444, 1978.
Wright DG, Kirkpatrick CH, Gallin JI: Effects of levamisole on normal and abnormal leukocyte locomotion. J Clin Invest 59: 941–950, 1977.
Rosenthal M, Trabert U, Müller W: Leucocytotoxic effect of levamisole. Lancet 1: 369, 1976.
Larter WE, John TJ, Sieber OF Jr, et al: Trimethoprimsulfamethoxazole treatment of Pneumocystis carinii pneumonitis. J Pediatr 92: 826–828, 1978.
Walzer PD, Perl DP, Krogstad Pi: Pneumocystis carinii pneumonia in the United States: Epidemiologic, diagnostic, and clinical features. Ann Intern Med 80: 83–93, 1974.
Watanakunakorn C, Glotzbecker C: Enhancement of the effects of antistaphylococcal antibiotics by aminoglycosides. Antimicrob Agents Chemother 6: 802–806, 1974.
Curry CR, Quie PG: Fungal septicemia in patients receiving parenteral hyperalimentation. N Engl J Med 285: 1221–1225, 1971.
Montgomerie JZ, Edwards JE Jr: Association of infection due to Candida albicans with intravenous hyperalimentation. J Infect Dis 137: 197–201, 1978.
Hill HR, Mitchell TG, Matsen JM, et al: Recovery from disseminated candidiasis in a premature neonate. Pediatrics 53: 748–752, 1974.
Parkman R, Gelfand EW, Rosen FS, et al: Severe combined immunodeficiency and adenosine deaminase deficiency. N Engl J Med 292: 714–719, 1975.
Stoop JW, Zegers BJM, Hendricks GFM, et al: Purine nucleoside phosphorylase deficiency associated with selective cellular immunodeficiency. N Engl J Med 96: 651–655, 1977.
Ackeret C, Pluss HJ, Hitzig WH: Hereditary severe combined immunodeficiency and adenosine deaminase deficiency. Pediatr Res 10: 67–70, 1976.
Lum LG, Tubergen DG, Corasti L, et al: Splenactomy in the management of the thrombocytopenia of the Wiskott—Aldrich Syndrome. N Engl J Med 302: 892–896, 1980.
Greenberg AH, Ray M, Tsai YT: Thymic alymphoplasia and dysgammaglobulinemia type I. Clinical, immunologic, and pathologic studies of one case. J Pediatr 75: 95–103, 1969.
Allibone EC, Goldie W, Marmon BP: Pneumocystis carinii pneumonia and progressive vaccines in siblings. Arch Dis Child 39: 26–34, 1964.
Wara DW, Goldstein AL, Doyle NE, et al: Thymosin activity in patients with cellular immunodeficiency. N Engl J led 292: 70–74, 1975.
Tiller TL Jr, Buckley RN: Transient hypogammaglobulinemia of infancy: Review of the literature, clinical and immunologic features of 11 new cases, and long-term followup. J Pediatr 92: 347–353, 1978.
Bruton OC: Agammaglobulinemia. Pediatrics 9: 722–728, 1952.
Davis SD: Antibody deficiency diseases. In Stiehm ER, Fulginti VA (eds): Immunologic Disorders in Infants and Children. WB Saunders, Philadelphia, 1973, pp. 184–198.
Wilfert CM, Buckley RH, Mohammakeimar T, et al: Persistent and fatal central-nervous-system echovirus infections in patients with agammaglobulinemia. N Engl J Med 26: 1485–1489, 1977.
Levitt D, Haber P, Rich K, et al: Hyper IgM immunodefi- 193. ciency. J Clin Invest 72: 1650–1657, 1983.
Ammann AI, Hong R: Selective IgA deficiency. In Stiehm ER, Fulginiti VA (eds): Immunologic Disorders in Infants and Children WB Saunders, Philadelphia, 1973, pp. 199214.
Strober W, Krakauer R, Klaeveman HL, et al: Secretory component deficiency: A disorder of the IgA immune system. N Engl J Med 294: 351–356, 1976.
Ammann AI, Hong R: Selective IgA deficiency: Presentation of 30 cases and a review of the literature. Medicine (Baltimore) 50: 223–236, 1971.
South MA, Cooper MD, Wollheim FA, et al: The IgA system. II. The clinical significance of IgA deficiency: Studies in patients with agammaglobulinemia and ataxia-telangiectasia. Am J Med 44: 168–178, 1978.
Douglas SD, Goldberg LS, Fudenberg HH: Clinical, serologic and leukocyte function studies on patients with idiopathic “acquired” agammaglobulinemia and their families. Medicine (Baltimore) 48: 48–53, 1970.
Day NK, Geiger H, Stroud R, et al: Cir deficiency: An inborn error associated with cutaneous and renal disease. J Clin Invest 51: 1102–1108, 1972.
Klemperer MR, Woodworth HC, Rosen FS, et al: Hereditary deficiency of the second component of complement (C’2) in man. J Clin Invest 45: 880–890, 1966.
Osterland CK, Espinoza L, Parker LP, et al: Inherited C2 deficiency and systemic lupus erythematosus studies on a family. Ann Intern Med 82: 323–328, 1975.
Gilliland BC, Schaller JG, Leddy JP, et al: Lupus syndrome in a C4-deficient child. Arthritis Rheum 18: 401, 1975.
Newman SL, Vogler LB, Feigin RD, et al: Recurrent septicemia associated with congenital deficiency of C2 and partial deficiency of factor B and the alternative complement pathway. N Engl J Med 299: 290–292, 1978.
Alper CA, Colton HR, Rosen FS, et al: Homozygous deficiency of C3 in a patient with repeated infections. Lancet 2: 1179–1181, 1972.
Miller ME, Nilsson UR: A familial deficiency of the phagocytosis-enhancing activity of serum related to a dysfunction of the fifth component of complement (C5). N Engl J Med 282: 354–358, 1970.
Miller ME, Kablenzer PG: Leiner’s disease and deficiency of C5. J Pediatr 80: 879–880, 1972.
Leiner C: Über Erythrodermia desquamativa, eine Eigenartige universelle Dermatose der Brustkinder. Arch Dermatol Syph 89: 163, 1908.
Hill HR, Hogan NA, Bale JF, et al: Evaluation of nonspecific (alternative pathway) opsonic activity by neutrophil chemiluminescence. Int Arch Allergy Appl Immunol 53: 490–497, 1977.
Neu RL, Stockman JA III, Spitzer RE: 46,XY/46,XY,21q-Mosaicism in an infant with neutropenia and properdin deficiency. J Med Genet 13: 332–334, 1976.
Bodey GP, Buckley M, Sathe YS, et al: Quantitative relationships between circulating leucocytes and infection in patients with acute leukemia. Ann Intern Med 64: 328–340, 1966.
Stossel TP: Phagocytosis. N Engl J Med 290: 717–723, 1974.
Kauder E, Mauer AM: Neutropenias of childhood. JPediatr 69: 147–157, 1966.
Kostmann R: Infantile genetic agranulocytosis. Acta Paediatr 45 (suppl 105): 1–78, 1956.
Zuelzer WW, Bajoghli M: Chronic granulocytopenia in childhood. Blood 23: 359–374, 1964.
Miller ME, Norman ME, Koblenzer PJ, et al: A new familial defect of neutrophil movement. J Lab Clin Med 82: 1–8, 1973.
Jacobs IC, Norman ME: A familial defect of neutrophil chemotaxis with asthma, eczema, and recurrent skin infections. Pediatr Res 11: 732–736, 1977.
Dahl MV, Greene WH Jr, Quie PG: Infection, dermatitis, increased IgE, and impaired neutrophil chemotaxis. Arch Dermatol 112: 1387–1390, 1976.
Hill HR: The syndrome of hyperimmunoglobulinemia E and recurrent infections. Am J Dis Child 136: 767–771, 1982.
Hill HR, Estensen RD, Hogan NA, et al: Severe staphylococcal disease associated with allergic manifestations, hyperimmunoglobulinemia E, and defective neutrophil chemotaxis. J Lab Clin Med 88: 796–806, 1976.
Hill HR, Williams PB, Krueger GG, et al: Recurrent staphylococcal abscesses associated with defective neutrophil chemotaxis and allergic rhinitis. Ann Intern Med 85: 39–43, 1976.
Buckley RH, Wray BB, Belmaker EZ: Extreme hyperimmunoglobulinemia E and undue susceptibility to infection. Pediatrics 49: 59–69, 1972.
Rubin IL, Griffiths RW, Hill HR: Allergen induced depression of neutrophil chemotaxis in allergic individuals. J Allergy Clin Immunol 62: 301–308, 1978.
Schopfer K, Baerlocher K, Price P, et al: Staphylococcal IgE antibodies, hyperimmunoglobulinemia E and Staphylococcal aureus infections. N Engl J Med 300: 835–838, 1979.
Butler HL, Byrne WI, Marmer DJ, et al: Depressed nuetrophil chemotaxis in infants with cow’s milk and/or soy protein intolerance. Pediatrics 67: 264–268, 1981.
Donabedian H, Ailing DW, Vallin JI: Levamisole is inferior to placebo in the hyperimmunoglobulin E recurrent infection (Job’s) syndrome. N Engl J Med 307: 290–292, 1982.
Mawhinney H, Killen M, Fleming WA, et al: The hyperimmunoglobulinemia E syndrome-A neutrophil chemotactic defect reversible by histamine H2 receptor blockade? Clin Immunol Immunopathol 17: 483–491, 1980.
Soderberg-Warner M, Rice-Mendoza CA, Mendoza GR, et al: Neutrophil and T lymphocyte characteristics of two patients with the hyper IgE syndrome. Pediatr Res 17: 820–824, 1983.
Björksten B,Lundmark KM: Recurrent bacterial infections in four siblings with neutropenia, eosinopenia, hyperimmunoglobulinemia A, and defective neutropenia, eosinopenia,eosinophil chemotaxis. J Infect Dis 133: 63–71, 1976
Boxer LA, Hedley-Whyte ET, Stossel TP: Neutrophil actin dysfunction and abnormal neutrophil behavior.N Engl J Med 291; 1903–1099, 1974.
Snyderman R, Altman LC, Frankel A, et al: Defective mononuclear leukocyte chemotaxis: A previously unrecognized immune dysfunction. Ann Intern Med 78: 509–513, 1973.
Gallin JL:Abnormal chemotaxis: Cellular and humoral components. In Bellanti JA, Dayton DH (eds): The Phagocytic Cell in Host Resistance Raven, New York, 1975, pp. 227248.
Klebanoff SJ: Myeloperoxidase—halide—hydrogen peroxidase antimicrobial system. J Bacteriol 95: 2131–2138, 1968.
Holmes B, Park BH, Malawista SE, et al: Chronic granulomatous disease in females: A deficiency of leukocyte glutathione peroxidase. N Engl J Med 283: 217–221, 1970.
Gray GR, Klebanoff SJ, Stamatoyannopoulos G, et al: Neutrophil dysfunction, chronic granulomatous disease, and non-spherocytic haemolytic anaemia caused by complete deficiency of glucose-6-phosphate dehydrogenase. Lancet 2: 530–534, 1973.
Segal AW, Cross AR, Garcia RC: Absence of cytochrome b-245 in chronic granulomatous disease. N Engl J Med 308: 245–251, 1983.
Kaplan EL, Laxdal T, Quie PG: Studies on polymorphonuclear leukocytes from patients with chronic granulomatous disease of childhood: Bactericidal capacity for streptococci. Pediatrics 41: 591–599, 1968.
Raubitschak AA, Levin AS, Stites DP, et al: Normal granulocyte infusion therapy for aspergillosis in chronic granulomatous disease. Pediatrics 51: 230–233, 1973.
Verronen P: Presumed disseminated BCG in a boy with chronic granulomatous disease of childhood. Acta Pediatr Scand 63: 627–630, 1974.
Cohen MS, Isturiz RE, Malech HL, et al: Fungal infection in chronic granulomatous disease. Am,/ Med 71:59–66, 1981.
Quie PG: Infections due to neutrophil malfunction. Medicine (Baltimore) 52: 411–417, 1973.
Jacobs RF, Wilson CB: Activity of antibiotics in chronic granulomatous disease granulocytes. Pediatr Res 17: 916919, 1983.
Salmon SE, Cline MJ, Schultz J, et al: Myeloperoxidase deficiency. N Engl J Med 282: 250–253, 1970.
Medoff G, Dismicker WE, Meade RH: A new therapeutic approach to Candida infections. Arch Intern Med 130:241–249, 1972.
Gregory L, Williams R, Thompson E: Leukocyte function in Down’s syndrome and acute leukemia. Lancet 1: 1359–1361, 1977.
Rosner F, Kozinn PJ, Jervis GA: Leukocyte function and serum immunoglobulins in Down’s syndrome. NY State J Med 73 :672–675, 1973.
Miller ME: Chemotactic function in the human neonate: Humoral and cellular aspects. Pediatr Res 5: 587–592, 1971.
Klein RB, Fischer TJ, Gard SEDecreased mononuclear and polymorphonuclear chemotaxis in human newborns, infants, and young children. Pediatrics467–472, 1977.
Tono-Oda T, Nakayama M, Uehara H, et al: Characteristics of impaired chemotactic function in cord blood leukocytes. Pediatr Res 13: 148–151, 1979.
Mills EL, Thompson T, Björksten B, et al: The chemiluminescence response and bactericidal activity of polymorphonuclear neutrophils from newborns and their mothers. Pediatrics 63: 429–434, 1979.
Wright WC Jr, Ank BJ, Herbert J, et al: Decreased bactericidal activity of leukocytes of stressed newborn infants. Pediatrics 56: 579–584, 1975.
Hemming VG, McClosky DW, Hill HR: Pneumonia in the neonate associated with group B streptococcal septicemia. Am J Dis Child 130: 1231–1233, 1976.
Headings DL, Overall JC Jr: Outbreak of meningitis in a newborn intensive care unit caused by a single Escherichia coli K1 serotype. J Pediatr 90: 99–102, 1977.
Hill HR, Hunt CE, Matsen JM: Nosocomial colonization with Klebsiella type 26 in a neonatal intensive care unit associated with an outbreak of sepsis, meningitis and necrotizing enterocolitis. J Pediatr 85: 415–419, 1974.
Pickering LK, Simon FA: Reevaluation of neonatal Hemophilus influenzae infections. South Med J 70: 205–208, 1977.
Filice GA, Cantrell HF, Smith AB: Listeria monocytogenes infection in neonates: Investigation of an epidemic. J Infect Dis 138: 17–23, 1978.
Bortolussi R, Thompson TR, Fern eri P: Early-onset pneumococcal sepsis in newborn infants. Pediatrics 60: 352–355, 1977.
Shigeoka AO, Hall RT, Hill HR: Blood-transfusion in group-B streptococcal sepsis. Lancet 1: 636–638, 1978.
Hill HR: Host defenses in the neonate: Prospects for enhancement. Semin Perinatol 9: 2–11, 1985.
Hill HR: Diagnosis and treatment of sepsis in the neonate. In Root RK, Sande MA (eds): Septic Shock. Churchill Livingstone, New York, 1985, pp. 219–232.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1988 Springer Science+Business Media New York
About this chapter
Cite this chapter
Hill, H.R. (1988). Infections Complicating Congenital Immunodeficiency Syndromes. In: Rubin, R.H., Young, L.S. (eds) Clinical Approach to Infection in the Compromised Host. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-6645-8_16
Download citation
DOI: https://doi.org/10.1007/978-1-4615-6645-8_16
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-6647-2
Online ISBN: 978-1-4615-6645-8
eBook Packages: Springer Book Archive